NCT00040014View on ClinicalTrials.gov

Open Label, Multicenter, Randomized, Controlled Study of IM or Oral Exemestane (Aromasin) in Postmenopausal Women

PHASE2TerminatedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

June 30, 2002

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions
Breast Neoplasms
Interventions
DRUG

exemestane

Trial Locations (1)

Unknown

Pfizer Investigational Site, Leicester

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY